EBS:NYSE
Emergent Biosolutions Inc
$6.98
arrow_downward
-1.13%(-0.080) 1D
$7.00
arrow_upward
+0.29% (+0.020)todayPre-market
Closed: Oct 12, 4:00:02 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EBS...
Open
$7.08
High
$7.33
Low
$6.95
Mkt. cap
357.89M
Avg. vol.
1.16M
Volume
4.96K
52-wk high
$14.06
52-wk low
$4.36
EPS
-$3.51
Beta
2.28
Shares outstanding
51.27M
No. of employees
900
Open
$7.08
High
$7.33
Low
$6.95
Mkt. cap
357.89M
Avg. vol.
1.16M
Volume
4.96K
52-wk high
$14.06
52-wk low
$4.36
EPS
-$3.51
Beta
2.28
Shares outstanding
51.27M
No. of employees
900
News stories
From web sources and news partners
Inc.com
·
25 minutes ago
The S&P 500’s Bull Market Just Turned 4. History Says the Next Year Is What Matters Most
Markets Media
·
1 hour ago
HKEX Offers S&P 500 & HKEX Tech 100 Index
The Motley Fool
·
5 minutes ago
Prediction: A Stock Market Crash Is Coming. Here's What Investors Should Do Based on Almost 7 Decades' Worth of History.
TradingView
·
4 hours ago
IXIC: Nasdaq Futures Shed 1% as Chip Selloff in Asia Triggers Trading Halt
Profile
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Among the company's products are the controversial BioThrax, the only anthrax vaccine licensed by the U.S. Food and Drug Administration and Narcan for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid.
During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants; however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded. Wikipedia
About Emergent Biosolutions Inc
CEORobert G. Kramer Sr. | Joseph C. Papa
Employees900
FoundedSep 5, 1998
HeadquartersRockville, Maryland, United States
SectorBiotechnology
Websiteemergentbiosolutions.com